In Britain experiencing several medications from COVID-19

Director test believes that the effect of check of drugs is exaggerated and the miracle is not worth waiting.

In the UK is the world’s largest test drugs for the treatment of patients with COVID-19. Both tested several drugs and their combinations, according to the newspaper The Guardian.

The goal of the project is to evaluate the effectiveness of certain drugs. In the study entitled the Restoration involved more than five thousand patients at 165 hospitals across the UK.

Patients randomly allocated one of the drugs or placebo. Each of the drugs tested on a group of 500-900 patients.

Directs the research of Professor Peter Horby from Oxford University, a specialist in infectious diseases and global health.

In the framework of the project doctors examined the antimalarial drug hydroxychloroquine and the antibiotic azithromycin. The President of the United States Donald trump claims that their use will help in the fight against coronavirus.

Also in the present study involved the combination of two antiretroviral drugs used for treatment of HIV lopinavir-ritonavir.

Another drug that plan to include study – immunomodulator, used for rheumatoid arthritis, for example, tocilizumab.

In addition, discuss the study treatments with the use reconvalescents the plasma obtained from the blood of people who recover from COVID-19 and develop antibodies to the virus.

Harbi emphasizes that his group is unlikely to find a “miracle cure”.

“I think we should temper people’s expectations in relation to these drugs. It is possible that some of them are effective, but probably their effect is negligible,” said Horby.

He noted that scientists want to identify the drugs that do help with COVID-19, and then explore them in combinations that can be truly effective.

Earlier it was reported that scientists found a cure for severe pneumonia in the coronavirus.

News from